SCHEMBL23488403

SCHEMBL23488403

O=C(O)c1ccc(NC(=O)c2cccnc2)nc1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HCAR3 P49019 2/20 0.75
SMN1; SMN2 Q16637 2/20 0.70
ALDH1A1 P00352 1/20 0.62
APP P05067 1/20 0.62
GAA P10253 1/20 0.62
HCAR2 Q8TDS4 1/20 0.62
CYP2C19 P33261 1/20 0.57
RAB9A P51151 3/20 0.57
NPC1 O15118 2/20 0.57
TP53 P04637 1/20 0.57
ALOX15 P16050 1/20 0.57
DEGS1 O15121 1/20 0.56
LMNA P02545 1/20 0.56
HIF1A Q16665 1/20 0.56
ROCK2 O75116 1/20 0.55
ROCK1 Q13464 1/20 0.55
KDM4E B2RXH2 1/20 0.55
KMT2A Q03164 1/20 0.55
HSD17B10 Q99714 1/20 0.54
POLB P06746 1/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23488400 0.87 SMN1; SMN2 (0.68) HCAR3SMN1; SMN2CYP2C19RAB9ANPC1
SCHEMBL2664544 0.86 HCAR3 (1.00) HCAR3SMN1; SMN2RAB9ANPC1DEGS1
SCHEMBL22983005 0.85 ALDH1A1 (0.68) HCAR3SMN1; SMN2ALDH1A1CYP2C19RAB9A
SCHEMBL31672283 0.83 DEGS1 (0.68) SMN1; SMN2GAACYP2C19RAB9ANPC1
SCHEMBL17040257 0.83 DEGS1 (0.68) SMN1; SMN2GAACYP2C19RAB9ANPC1
SCHEMBL11887841 0.82 SMN1; SMN2 (1.00) SMN1; SMN2ALDH1A1CYP2C19RAB9ANPC1
SCHEMBL15291342 0.82 SMN1; SMN2 (0.70) SMN1; SMN2ALDH1A1GAACYP2C19RAB9A
SCHEMBL6646471 0.80 RAB9A (0.70) SMN1; SMN2RAB9ANPC1LMNAHIF1A
SCHEMBL31414959 0.80 RAB9A (0.70) SMN1; SMN2RAB9ANPC1LMNAHIF1A
SCHEMBL7329481 0.80 ROCK2 (0.73) HCAR3SMN1; SMN2ALDH1A1APPGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN SANOFI (FR) 2021-06-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210170033-A1 NOVEL CONJUGATES OF A PHARMACEUTICAL AGENT AND A MOIETY CAPABLE OF BINDING TO A GLUCOSE SENSING PROTEIN GPR119, SLC2A8, SLC2A4 HCAR3 447/4885SMN1; SMN2 3945/4885ALDH1A1 1627/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.